AcuFocus Gets Investment From Bausch & Lomb

Irvine-based AcuFocus has received a strategic investment from Bausch & Lomb, which also has secured an exclusive option to purchase the firm, according to Bausch & Lomb. Amount of the investment was not disclosed. AcuFocus said that it would use the investment to accelerate and broaden the company's efforts to bring its technology to market. AcuFocus is developing corneal inlay technology for the treatment of presbyopia. More information »